- Home
- BLDR vs EXEL Comparison
BLDR vs EXEL Comparison
Compare BLDR & EXEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BLDR
- EXEL
- Stock Information
- Founded
- BLDR 1998
- EXEL 1994
- Country
- BLDR United States
- EXEL United States
- Employees
- BLDR N/A
- EXEL N/A
- Industry
- BLDR RETAIL: Building Materials
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BLDR Consumer Discretionary
- EXEL Health Care
- Exchange
- BLDR Nasdaq
- EXEL Nasdaq
- Market Cap
- BLDR 12.4B
- EXEL 12.0B
- IPO Year
- BLDR 2005
- EXEL 2000
- Fundamental
- Price
- BLDR $132.08
- EXEL $37.27
- Analyst Decision
- BLDR Buy
- EXEL Buy
- Analyst Count
- BLDR 19
- EXEL 21
- Target Price
- BLDR $155.58
- EXEL $44.00
- AVG Volume (30 Days)
- BLDR 2.1M
- EXEL 3.7M
- Earning Date
- BLDR 07-31-2025
- EXEL 07-28-2025
- Dividend Yield
- BLDR N/A
- EXEL N/A
- EPS Growth
- BLDR N/A
- EXEL 81.76
- EPS
- BLDR 6.61
- EXEL 2.08
- Revenue
- BLDR $15,944,360,000.00
- EXEL $2,230,005,000.00
- Revenue This Year
- BLDR $1.03
- EXEL $9.88
- Revenue Next Year
- BLDR $3.02
- EXEL $12.59
- P/E Ratio
- BLDR $19.76
- EXEL $18.16
- Revenue Growth
- BLDR N/A
- EXEL 10.73
- 52 Week Low
- BLDR $102.60
- EXEL $23.21
- 52 Week High
- BLDR $203.14
- EXEL $49.62
- Technical
- Relative Strength Index (RSI)
- BLDR 56.83
- EXEL 34.08
- Support Level
- BLDR $118.17
- EXEL $36.37
- Resistance Level
- BLDR $134.46
- EXEL $38.09
- Average True Range (ATR)
- BLDR 5.02
- EXEL 1.28
- MACD
- BLDR -0.36
- EXEL -0.80
- Stochastic Oscillator
- BLDR 75.35
- EXEL 11.85
About BLDR Builders FirstSource Inc.
Builders FirstSource Inc is a manufacturer and supplier of building materials. The company offers structural and related building products such as factory-built roof and floor trusses, wall panels and stairs, vinyl windows, custom millwork and trim, and engineered wood. The products can be designed for each home individually and are installed by Builders FirstSource. The company's construction-related services include professional installation, turn-key framing, and shell construction. Builders FirstSource's customers range from large production builders to small custom homebuilders.
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.